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ZnSO4 promotes the binding of Clq to immune complexes over the same concentration range 
(10-5-10-4 M) that it inhibits binding of Cl to cell-bound immunoglobulin [Biochem. Biophys. Res. Com- 
mun. (1981) 103, 856-8621. At higher concentrations (IOW3-2 x lo-’ M) ZnSOr inhibited the binding of 
Clq to immune complexes, [Ki = (6 it 2) x lo-’ M]. This inhibition could be correlated with a 
ZnSO&nduced change in the tr~tophan fluorescence of Clq [AF 25%, Kd = (9.9 f 1.0) x lo+’ M]. 
Immune complex Complement Zinc Fluorescence 
1. INTRODUCTION 
The first step in activation of the classical com- 
plement pathway is binding of complement com- 
ponent Cl to aggregated immunoglobulin [l]. Cl 
is a macro-molecular complex containing 3 pro- 
teins: Ciq, Clr and Cls. Clq is responsible for 
binding to immunoglobulins, while Clr and Cls 
are zymogens which are converted into serine pro- 
teases during activation of Cl [2]. The integrity of 
Cl is dependent on the presence of Ca2’ [3], but 
the effects of other divalent cations on the classical 
complement pathway have hitherto received little 
attention. Cl binding to cell-bound immuno- 
globulin is inhibited by Zn2+ over 1O-s-1O-4 M 
[4]. The results presented below indicate that Zn2+ 
in this concentration range promotes the binding 
of Clq to immune complexes, while the binding is 
inhibited by Zn2’ over 10-3-10-2 M. 
2. MATERIALS AND METHODS 
2.1, Proteins 2.4. Data analysis 
Clq was prepared from human serum, and 
labelled with “‘I (using lactoperoxidase) using the 
Kinetic constants for Clq binding to immune 
complexes, and Zn2’ binding to Clq were obtained 
procedure in [S]. Rabbit ~ti-ov~bumin IgG and by non-linear regression analysis [8] ~suming that 
equivalence ovalbumin : IgG immune complexes both binding processes are of the non-cooperative 
were prepared as in 161. (Michaelis-Menten) type. 
2.2. Clq binding assay 
The binding of 12sI-labelled Clq to immune 
complexes was measured as in [7] with the follow- 
ing modifications: the reaction volume was 0.3 ml, 
the buffer was 0.03 M Tris-HCl (pH 7.2), con- 
taining 0.15% (w/v) gelatin, and the reaction time 
was 40 min. The effect of added ZnSO4 on the 
ionic strength of the assay medium was corrected 
for by addition of N&l to maintain the ionic 
strength at 0.15. 
2.3. Fluorescence measurements 
The effects of Zn2+ on the tryptophan 
fluorescence of IgG and Clq were determined us- 
ing an Aminco SPFSOO spectrofluorimeter, with 
the cell holder thermostatted at 37°C. The 
fluorescence of the protein samples (0.2-l.OpM, 
in 0.05 M Tris-HCI, 0.1 M NaCl, pH 7.2) was 
measured at 340 nm, following excitation at 
295 nm. 
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3. RESULTS AND DISCUSSION 
The dependence of Clq binding on ZnS04 con- 
centration at various fixed immune complex con- 
centrations, is shown in fig.1. Two different ef- 
fects of ZnS04 are apparent; enhancement of Clq 
binding to immune complexes by ZnS04 over 
10-5-10-3 M, and inhibition of binding by ZnS04 
over 10m3-2 x 10m2 M. The effects of ZnS04 on 
the kinetic parameters of the binding process were 
investigated in both concentration ranges. The 
data shown in fig.2 show the dependence of bound 
Clq on the free Clq concentration, at various fix- 
ed ZnS04 levels in the low concentration range. 
The secondary plots (fig.2, insert) showed that on- 
ly the slopes of the double reciprocal plots of fig.2 
changed with ZnS04 concentration. Linear regres- 
sion analysis of the slope replot gave an apparent 
activation constant for ZnS04 of (1.1 * 0.1) x 
1O-4 M. 
The results shown in fig.3 show the dependence 
of bound Clq on free Clq concentration at ZnS04 
levels between 1 x 10m3 M and 1.5 x 10m2 M. 
Again, only the slopes of the double reciprocal 
plots changed with ZnS04 concentration: linear 
regression analysis of the slope replot (fig.3, insert) 
gave an apparent inhibition constant of (6 + 2) x 
1O-3 M. 
Addition of ZnS04 over lo-’ x 10e4 M to either 
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Fig.1. The effect of ZnS04 on Clq binding to immune 
complexes. The binding of ‘*‘I-labelled Clq (0.1 pg/ml, 
6 x lo5 cpm/,ug) to lO,ug/ml (O-U), 20pg/ml 
(M), and 40pg/ml (C-G) immune complexes was 
measured at the indicated ZnS04 concentrations. ZnS04 
had no effect on the amount of Clq precipitated (5 f 
2’70) in the absence of immune complexes. 
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Fig.2. Enhancement of Clq binding to immune 
complexes by ZnS04. The binding of ‘251-labelled Clq 
(9 x lo3 cpm/,ug) to 60~g/ml immune complexes was 
measured in the absence (o---+) and in the presence of 
3 x lo-’ M (H), 6 x 1O-5 M (W--U), 1 x 1O-4 M 
(W-O) and 3 x 10e4 M (C--O) ZnS04. The lines 
shown were obtained by non-linear regression analysis 
[8] on the primary data. Insert: dependence of the slopes 
(o--m) and intercepts (O--G) of the double reciprocal 
plots on ZnS04 concentration. 
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Fig.3. Inhibition of Clq binding to immune complexes 
by ZnS04. The binding of ‘251-labelled Clq (9 x 
lo3 cpm/pg) to immune complexes was measured in the 
presence of ZnSO4 at: 1 x 10m3 M (M); 5 x 10m3 M 
(o--o); 1 x lo-* M (O---a); and 1.5 x lo-’ M 
(H). The lines shown were obtained by non-linear 
regression analysis [8] on the primary data. Insert: 
Dependence on the slope of the double reciprocal lines 
on ZnSO4 concentration. 
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Clq or IgG had no significant effect on the tryp- 
tophan fluorescence of either protein. Further- 
more, the tryptophan fluorescence of IgG was 
unaffected by ZnS04 over 10e3 - 2 x lo-’ M. 
However, addition of ZnS04 in this range to 
C 1 q was associated with changes in the tryptophan 
fluorescence of the protein (fig.4). Non-linear 
regression analysis on these data gave a maximum 
fluorescence change of 24.6 f 1370, associated 
with an apparent dissociation constant for ZnS04 
binding of (9.9 f 1.0) x 10e3 M. 
The results shown in fig.2 indicate that Zn’+ 
over 10-5-10-4 M promotes the binding of Clq to 
immune complexes. It would appear that this ef- 
fect arises from a relatively subtle change in the 
structure of Clq, in that Zn2+ had no effect on the 
tryptophan fluorescence of the protein over 
1O-5-1O-4 M. On the other hand, the inhibition of 
C lq binding by Zn2+ which was characterised by 
an inhibition constant of (6 + 2) x 10m3 M could 
be correlated with a 25% decrease in the tryp- 
tophan fluorescence of the protein, with a dissocia- 
tion constant of (9.9 f 1.0) x 10e3 M. Although it 
is not possible to deduce the extent of the struc- 
tural change from the magnitude of the 
fluorescence change, this inhibition may be 
associated with a more extensive change in the 
structure of Clq than the enhancement of binding 
observed at lower Zn2+ concentrations. Although 
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Fig.4. Effect of ZnS04 on the tryptophan fluorescence 
of Clq. The change in fluorescence of Clq (0.22rM) 
following addition of ZnS04 was determined as in 
section 2. The line shown was obtained by non-linear 
regression analysis [S] on the primary data. 
the Zn2+ mediated enhancement of Clq binding to 
immune complexes falls in the same concentration 
range (1O-5-1O-4 M) as the Zn’+-mediated inhibi- 
tion of Cl binding to cell-bound immunoglobulin 
[4] it is not clear whether the two phenomena rise 
from similar mechanisms. The latter system is far 
more complex, as the binding of Clr and Cls to 
Clq influences the conformation of Clq [9,10], 
and the binding of Clq to aggregated im- 
munoglobulin alters both its structure [ 111, and its 
affinity for the Clr2 Cls2 tetramer [12]. Thus, 
although the Zn2+-induced inhibition of Cl bind- 
ing may arise from the same mechanism as the 
Zn2+-mediated promotion of Clq binding to im- 
mune complexes, the possibility that the inhibition 
is mediated via Clr or Cls can not be excluded. 
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